Trademark: 88280376
Word
VYNCRO
Status
Dead
Status Code
606
Status Date
Monday, July 25, 2022
Serial Number
88280376
Mark Type
4000
Filing Date
Tuesday, January 29, 2019
Published for Opposition
Tuesday, April 23, 2019
Abandoned Date
Monday, July 25, 2022

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Jul 25, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 25, 2022
Abandonment - No Use Statement Filed
Jan 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 6, 2022
Sou Extension 5 Granted
Dec 16, 2021
Sou Extension 5 Filed
Dec 28, 2021
Case Assigned To Intent To Use Paralegal
Dec 16, 2021
Teas Extension Received
Jun 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 9, 2021
Sou Extension 4 Granted
Jun 9, 2021
Sou Extension 4 Filed
Jun 9, 2021
Teas Extension Received
Dec 16, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2020
Sou Extension 3 Granted
Dec 14, 2020
Sou Extension 3 Filed
Dec 14, 2020
Teas Extension Received
Jun 17, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2020
Sou Extension 2 Granted
Jun 15, 2020
Sou Extension 2 Filed
Jun 15, 2020
Teas Extension Received
Dec 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2019
Sou Extension 1 Granted
Dec 17, 2019
Sou Extension 1 Filed
Dec 17, 2019
Teas Extension Received
Jun 18, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 23, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 23, 2019
Published For Opposition
Apr 3, 2019
Notification Of Notice Of Publication E-Mailed
Mar 11, 2019
Approved For Pub - Principal Register
Mar 10, 2019
Assigned To Examiner
Feb 21, 2019
New Application Office Supplied Data Entered In Tram
Feb 1, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24